Diversity of LEF/TCF action in development and disease

Oncogene

Volumn 25, Issue 57, 2006, Pages 7492-7504

  Arce, L ^a   Yokoyama, N N ^a   Waterman, M L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

catenin; LEF; TCF; Wnt

Indexed keywords

BETA CATENIN; LYMPHOID ENHANCER FACTOR 1; T CELL FACTOR PROTEIN; WNT PROTEIN;

ALTERNATIVE RNA SPLICING; CANCER; CELL NUCLEUS; CELL TRANSFORMATION; COELENTERATE; DNA RESPONSIVE ELEMENT; FLY; GENE DELETION; GENE REPRESSION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; REVIEW; SIGNAL TRANSDUCTION; VERTEBRATE; WORM;

ALTERNATIVE SPLICING; ANIMALS; CELL NUCLEUS; DNA; GENE EXPRESSION REGULATION; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MODELS, GENETIC; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

HYDRA; VERTEBRATA;

EID: 33845355511     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210056     Document Type: Review

References (118)

1. Amir AL, Barua M, McKnight NC, Cheng S, Yuan X, Balk SP. (2003). A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4. J Biol Chem 278: 30828-30834.
2. Atcha FA, Munguia JE, Li TW, Hovanes K, Waterman ML. (2003). A new beta -catenin dependent activation domain in T cell factor. J Biol Chem 278: 16169-16175.
3. Balmelle N, Zamarreno N, Krangel MS, Hernandez-Munain C. (2004). Developmental activation of the TCR alpha enhancer requires functional collaboration among proteins bound inside and outside the core enhancer. J Immunol 173: 5054-5063.
4. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R et al. (1996). Functional interaction of b-catenin with the transcription factor LEF-1. Nature 382: 638-642.
5. Beland M, Pilon N, Houle M, Oh K, Sylvestre JR, Prinos P et al. (2004). Cdx1 autoregulation is governed by a novel Cdx1-LEF1 transcription complex. Mol Cell Biol 24: 5028-5038.
6. Boras K, Hamel PA. (2002). Alx4 binding to LEF-1 regulates N-CAM promoter activity. J Biol Chem 277: 1120-1127.
7. Brannon M, Brown JD, Bates R, Kimelman D, Moon RT. (1999). XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development. Development 126: 3159-3170.
8. Brannon M, Gomperts M, Sumoy L, Moon RT, Kimelman D. (1997). A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus. Genes Dev 11: 2359-2370.
9. Brantjes H, Roose J, van De Wetering M, Clevers H. (2001). All TCF HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Res 29: 1410-1419.
10. Bruhn L, Munnerly A, Grosschedl R. (1997). ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCR alpha enhancer function. Genes Dev 11: 640-653.
11. Brunner E, Peter O, Schweizer L, Basler K. (1997). Pangolin encodes a LEF-1 homologue that acts downstream of Armadillo to transduce the Wingless signal in Drosophila. Nature 385: 829-833.
12. a enhancer in T cells. Genes Dev 7: 2418-2430.
13. Cavallo RA, Cox RT, Moline MM, Roose J, Polevoy GA, Clevers H et al. (1998). Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature 395: 604-608.
14. Cordray P, Satterwhite DJ. (2005). TGF-beta induces novel Lef-1 splice variants through a Smad-independent signaling pathway. Dev Dyn 232: 969-978.
15. Crawford HC, Fingleton B, Gustavson MD, Kurpios N, Wagenaar RA, Hassell JA et al. (2001). The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol Cell Biol 21: 1370-1383.
16. Cuilliere-Dartigues P, El-Bchiri J, Krimi A, Buhard O, Fontanges P, Flejou JF et al. (2006). TCF-4 isoforms absent in TCF-4 mutated MSI-H colorectal cancer cells colocalize with nuclear CtBP and repress TCF-4-mediated transcription. Oncogene 25: 4441-4448.
17. Daniels DL, Weis WI. (2005). Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol 12: 364-371.
18. DasGupta R, Fuchs E. (1999). Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 126: 4557-4568.
19. Deltour S, Pinte S, Guerardel C, Wasylyk B, Leprince D. (2002). The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Mol Cell Biol 22: 4890-4901.
20. Dorsky RI, Itoh M, Moon RT, Chitnis A. (2003). Two tcf3 genes cooperate to pattern the zebrafish brain. Development 130: 1937-1947.
21. Dorsky RI, Raible DW, Moon RT. (2000). Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev 14: 158-162.
22. Dorsky RI, Sheldahl LC, Moon RT. (2002). A transgenic Lef1/beta-catenin-dependent reporter is expressed in spatially restricted domains throughout zebrafish development. Dev Biol 241: 229-237.
23. Duval A, Gayet J, Zhou XP, Iacopetta B, Thomas G, Hamelin R. (1999). Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability. Cancer Res 59: 4213-4215.
24. Duval A, Rolland S, Tubacher E, Bui H, Thomas G, Hamelin R. (2000). The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res 60: 3872-3879.
25. El-Tanani M, Platt-Higgins A, Rudland PS, Campbell FC. (2004). Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. J Biol Chem 279: 20794-20806.
26. Fang M, Li J, Blauwkamp T, Bhambhani C, Campbell N, Cadigan KM. (2006). C-terminal-binding protein directly activates and represses Wnt transcriptional targets in Drosophila. EMBO J 25: 2735-2745.
27. Galceran J, Farinas I, Depew MJ, Clevers H, Grosschedl R. (1999). Wnt3a-/-like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. Genes Dev 13: 709-717.
28. Gay F, Calvo D, Lo MC, Ceron J, Maduro M, Lin R et al. (2003). Acetylation regulates subcellular localization of the Wnt signaling nuclear effector POP-1. Genes Dev 17: 717-722.
29. Ghogomu SM, van Venrooy S, Ritthaler M, Wedlich D, Gradl D. (2006). HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription. J Biol Chem 281: 1755-1764.
30. Giese K, Amsterdam A, Grosschedl R. (1991). DNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1. Genes Dev 5: 2567-2578.
31. Giese K, Cox J, Grosscheldl R. (1992). The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69: 185-196.
32. Giese K, Kingsley C, Kirshner JR, Grosschedl R. (1995). Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev 9: 995-1008.
33. Gradl D, Konig A, Wedlich D. (2002). Functional diversity of Xenopus lymphoid enhancer factor/T-cell factor transcription factors relies on combinations of activating and repressing elements. J Biol Chem 277: 14159-14171.
34. Graham TA, Ferkey DM, Mao F, Kimelman D, Xu W. (2001). Tcf4 can specifically recognize beta-catenin using alternative conformations. Nat Struct Biol 8: 1048-1052.
35. Graham TA, Weaver C, Mao F, Kimelman D, Xu W. (2000). Crystal structure of a beta-catenin/Tcf complex. Cell 103: 885-896.
36. Grosschedl R, Giese K, Pagel J. (1994). HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet 10: 94-100.
37. Hamada F, Bienz M. (2004). The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF. Dev Cell 7: 677-685.
38. Hammerlein A, Weiske J, Huber O. (2005). A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex. Cell Mol Life Sci 62: 606-618.
39. Haremaki T, Tanaka Y, Hongo I, Yuge M, Okamoto H. (2003). Integration of multiple signal transducing pathways on Fgf response elements of the Xenopus caudal homologue Xcad3. Development 130: 4907-4917.
40. Hecht A, Stemmler MP. (2003). Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4. J Biol Chem 278: 3776-3785.
41. Held W, Clevers H, Grosschedl R. (2003). Redundant functions of TCF-1 and LEF-1 during T and NK cell development, but unique role of TCF-1 for Ly49 NK cell receptor acquisition. Eur J Immunol 33: 1393-1398.
42. Hikasa H, Sokol SY. (2004). The involvement of Frodo in TCF-dependent signaling and neural tissue development. Development 131: 4725-4734.
43. Houston DW, Kofron M, Resnik E, Langland R, Destree O, Wylie C et al. (2002). Repression of organizer genes in dorsal and ventral Xenopus cells mediated by maternal XTcf3. Development 129: 4015-4025.
44. Hovanes K, Li TW, Munguia JE, Truong T, Milovanovic T, Lawrence Marsh J et al. (2001). Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 28: 53-57.
45. Hovanes K, Li TWH, Waterman ML. (2000). The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res 28: 1994-2003.
46. Hu MC, Rosenblum ND. (2005). Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Development 132: 215-225.
47. Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann B, Kemler R. (1996). Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech Dev 59: 3-10.
48. Hurlstone A, Clevers H. (2002). T-cell factors: turn-ons and turn-offs. EMBO J 21: 2303-2311.
49. Hussein SM, Duff EK, Sirard C. (2003). Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem 278: 48805-48814.
50. Ishitani T, Matsumoto K, Chitnis AB, Itoh M. (2005). Nrarp functions to modulate neural-crest-cell differentiation by regulating LEF1 protein stability. Nat Cell Biol 7: 1106-1112.
51. Ishitani T, Ninomiya-Tsuji J, Matsumoto K. (2003). Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling. Mol Cell Biol 23: 1379-1389.
52. Ishitani T, Ninomiya-Tsuji J, Nagai S, Nishita M, Meneghini M, Barker N et al. (1999). The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature 399: 798-802.
53. Jamora C, DasGupta R, Kocieniewski P, Fuchs E. (2003). Links between signal transduction, transcription and adhesion in epithelial bud development. Nature 422: 317-322.
54. Kahler RA, Westendorf JJ. (2003). Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. J Biol Chem 278: 11937-11944.
55. Kennell JA, O'Leary EE, Gummow BM, Hammer GD, MacDougald OA. (2003). T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors. Mol Cell Biol 23: 5366-5375.
56. Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR et al. (2000). Gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes Dev 14: 1319-1331.
57. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ et al. (1998a). Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19: 379-383.
58. Korinek V, Barker N, Willert K, Molenaar M, Roose J, Wagenaar G, Markman M et al. (1998b). Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse. Mol Cell Biol 18: 1248-1256.
59. Kunz M, Herrmann M, Wedlich D, Gradl D. (2004). Autoregulation of canonical Wnt signaling controls midbrain development. Dev Biol 273: 390-401.
60. Kusano S, Raab-Traub N. (2002). I-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways. Mol Cell Biol 22: 6393-6405.
61. Labbe E, Letamendia A, Attisano L. (2000). Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci USA 97: 8358-8363.
62. Levanon D, Goldstein RE, Bernstein Y, Tang H, Goldenberg D, Stifani S et al. (1998). Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc Natl Acad Sci USA 95: 11590-11595.
63. Li TW, Ting JH, Yokoyama NN, Bernstein A, van de Wetering M, Waterman ML. (2006). Wnt activation and alternative promoter repression of LEF1 in colon cancer. Mol Cell Biol 26: 5284-5299.
64. Liu F, van den Broek O, Destree O, Hoppler S. (2005). Distinct roles for Xenopus Tcf/Lef genes in mediating specific responses to Wnt/{beta}-catenin signalling in mesoderm development. Development 132: 5375-5385.
65. Lo MC, Gay F, Odom R, Shi Y, Lin R. (2004). Phosphorylation by the beta-catenin/MAPK complex promotes 14-3-3-mediated nuclear export of TCF/POP-1 in signal-responsive cells in C. elegans. Cell 117: 95-106.
66. Love JJ, Li X, Case DA, Giese K, Grosschedl R, Wright PE. (1995). Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature 376: 791-795.
67. Maduro MF, Kasmir JJ, Zhu J, Rothman JH. (2005). The Wnt effector POP-1 and the PAL-1/Caudal homeoprotein collaborate with SKN-1 to activate C. elegans endoderm development. Dev Biol 285: 510-523.
68. Meneghini MD, Ishitani T, Carter JC, Hisamoto N, Ninomiya-Tsuji J, Thorpe CJ et al. (1999). MAP kinase and Wnt pathways converge to downregulate an HMG-domain repressor in Caenorhabditis elegans. Nature 399: 793-797.
69. Merrill BJ, Gat U, DasGupta R, Fuchs E. (2001). Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev 15: 1688-1705.
70. Merrill BJ, Pasolli HA, Polak L, Rendl M, Garcia-Garcia MJ, Anderson KV et al. (2004). Tcf3: a transcriptional regulator of axis induction in the early embryo. Development 131: 263-274.
71. Miravet S, Piedra J, Miro F, Itarte E, Garcia de Herreros A, Dunach M. (2002). The transcriptional factor Tcf-4 contains different binding sites for beta-catenin and plakoglobin. J Biol Chem 277: 1884-1891.
72. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V et al. (1996). XTCF-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 86: 391-399.
73. Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H et al. (2000). Interaction between Wnt and TGFβ signalling pathways during formation of Spemann's organizer. Nature 403: 781-783.
74. Okamura R, Sigvardsson M, Galceran J, Verbeek S, Clevers H, Grosschedl R. (1998). Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1. Immunity 8: 11-20.
75. Oosterwegel M, van de Wetering M, Holstege FC, Prosser HM, Owen MJ, Clevers HC. (1991). TCF-1, a T cell-specific transcription factor of the HMG box family, interacts with sequence motifs in the TCR beta and TCR delta enhancers. Int Immuno 3: 1189-1192.
76. Park JI, Kim SW, Lyons JP, Ji H, Nguyen TT, Cho K et al. (2005). Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets. Dev Cell 8: 843-854.
77. Payre F, Vincent A, Carreno S. (1999). ovo/svb integrates Wingless and DER pathways to control epidermis differentiation. Nature 400: 271-275.
78. Pereira L, Yi F, Merrill BJ. (2006). Repression of nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal. Mol Cell Biol (E-pub ahead of print).
79. Prieve MG, Guttridge KL, Munguia JE, Waterman ML. (1998). Differential importin-a recognition and nuclear transport by nuclear localization signals within the high-mobility-group DNA binding domains of lymphoid enhancer factor 1 and T-cell factor 1. Mol Cell Biol 18: 4819-4832.
80. Pukrop T, Gradl D, Henningfeld KA, Knochel W, Wedlich D, Kuhl M. (2001). Identification of two regulatory elements within the high mobility group box transcription factor XTCF-4. J Biol Chem 276: 8968-8978.
81. Riese J, Yu X, Munnerlyn A, Eresh S, Hsu SC, Grosschedl R et al. (1997). LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic. Cell 88: 777-787.
82. Roel G, Hamilton FS, Gent Y, Bain AA, Destree O, Hoppler S. (2002). Lef-1 and Tcf-3 transcription factors mediate tissue-specific Wnt signaling during Xenopus development. Curr Biol 12: 1941-1945.
83. Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R et al. (1999). Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 285: 1923-1926.
84. Roose J, Molenaar M, Peterson J, Hurenkamp J, Brantjes H, Moerer P et al. (1998). The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature 395: 608-612.
85. Sachdev S, Bruhn L, Sieber H, Pichler A, Melchior F, Grosschedl R. (2001). PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev 15: 3088-3103.
86. Saito H, Yasumoto K, Takeda K, Takahashi K, Fukuzaki A, Orikasa S et al. (2002). Melanocyte-specific microphthalmia-associated transcription factor isoform activates its own gene promoter through physical interaction with lymphoid-enhancing factor 1. J Biol Chem 277: 28787-28794.
87. Sheridan PL, Sheline CT, Cannon K, Voz ML, Pazin MJ et al. (1995). Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev 9: 2090-2104.
88. Shetty P, Lo MC, Robertson SM, Lin R. (2005). C. elegans TCF protein, POP-1, converts from repressor to activator as a result of Wnt-induced lowering of nuclear levels. Dev Biol 285: 584-592.
89. Shulewitz M, Soloviev I, Wu T, Koeppen H, Polakis P, Sakanaka C. (2006). Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer. Oncogene 25: 4361-4369.
90. Sierra J, Yoshida T, Joazeiro CA, Jones KA. (2006). The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev 20: 586-600.
91. Snider L, Tapscott SJ. (2005). XIC is required for Siamois activity and dorsoanterior development. Mol Cell Biol 25: 5061-5072.
92. Snider L, Thirlwell H, Miller JR, Moon RT, Groudine M, Tapscott SJ. (2001). Inhibition of Tcf3 binding by I-mfa domain proteins. Mol Cell Biol 21: 1866-1873.
93. Spring CM, Kelly KF, O'Kelly I, Graham M, Crawford HC, Daniel JM. (2005). The catenin p120ctn inhibits Kaiso-mediated transcriptional repression of the beta-catenin/TCF target gene matrilysin. Exp Cell Res 305: 253-265.
94. Standley HJ, Destree O, Kofron M, Wylie C, Heasman J. (2006). Maternal XTcf1 and XTcf4 have distinct roles in regulating Wnt target genes. Dev Biol 289: 318-328.
95. Stankovic-Valentin N, Verger A, Deltour-Balerdi S, Quinlan KG, Crossley M, Leprince D. (2006). A L225A substitution in the human tumour suppressor HIC1 abolishes its interaction with the corepressor CtBP. FEBS J 273: 2879-2890.
96. Takeda H, Lyle S, Lazar AJ, Zouboulis CC, Smyth I, Watt FM. (2006). Human sebaceous tumors harbor inactivating mutations in LEF1. Nat Med 12: 395-397.
97. Theisen H, Haerry TE, O'Connor MB, Marsh JL. (1996). Developmental territories created by mutual antagonism between wingless and decapentaplegic. Development 122: 3939-3948.
98. Tutter AV, Fryer CJ, Jones KA. (2001). Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro. Genes Dev 15: 3342-3354.
99. Vadlamudi U, Espinoza HM, Ganga M, Martin DM, Liu X, Engelhardt JF et al. (2005). PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. J Cell Sci 118: 1129-1137.
100. Valenta T, Lukas J, Doubravska L, Fafilek B, Korinek V. (2006). HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies. EMBO J 25: 2326-2337.
101. Valenta T, Lukas J, Korinek V. (2003). HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells. Nucleic Acids Res 31: 2369-2380.
102. van Beest M, Dooijes D, van De Wetering M, Kjaerulff S, Bonvin A, Nielsen O et al. (2000). Sequence-specific high mobility group box factors recognize 10-12-base pair minor groove motifs. J Biol Chem 275: 27266-27273.
103. van de Wetering M, Castrop J, Korinek V, Clevers H. (1996). Extensive alternative splicing and dual promoter usage generate Tcf-protein isoforms with differential transcription control properties. Mol Cell Biol 16: 745-752.
104. van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, Loureiro J et al. (1997). Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88: 789-799.
105. van de Wetering M, Clevers H. (1992). Sequence-specific interaction of the HMG box proteins TCF-1 and SRY occurs within the minor groove of a Watson-Crick double helix. EMBO J 11: 3039-3044.
106. van Genderen C, Okamura R, Farinas I, Quo R, Parslow T, Bruhn L et al. (1994). Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev 8: 2691-2703.
107. van Noort M, Clevers H. (2002). TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev Biol 244: 1-8.
108. van Roy FM, McCrea PD. (2005). A role for Kaiso-p120ctn complexes in cancer? Nat Rev Cancer 5: 956-964.
109. Veien ES, Grierson MJ, Saund RS, Dorsky RI. (2005). Expression pattern of zebrafish tcf7 suggests unexplored domains of Wnt/beta-catenin activity. Dev Dyn 233: 233-239.
110. Verbeek S, Izon D, Hofhuis F, Robanus-Maandag E, te Riele H, van de Wetering M et al. (1995). An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 374: 70-74.
111. Waltzer L, Bienz M. (1998). Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling. Nature 395: 521-525.
112. Waterman ML. (2004). Lymphoid enhancer factor/T cell factor expression in colorectal cancer. Cancer Metastasis Rev 23: 41-52.
113. Weerkamp F, Baert MR, Naber BA, Koster EE, de Haas EF, Atkuri KR et al. (2006). Wnt signaling in the thymus is regulated by differential expression of intracellular signaling molecules. Proc Natl Acad Sci USA 103: 3322-3326.
114. Willert K, Jones KA. (2006). Wnt signaling: is the party in the nucleus? Genes Dev 20: 1394-1404.
115. Willinger T, Freeman T, Herbert M, Hasegawa H, McMichael AJ, Callan MF. (2006). Human naive CD8T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo. J Immunol 176: 1439-1446.
116. Yamamoto H, Ihara M, Matsuura Y, Kikuchi A. (2003). Sumoylation is involved in beta-catenin-dependent activation of Tcf-4. EMBO J 22: 2047-2059.
117. Yasumoto K, Takeda K, Saito H, Watanabe K, Takahashi K, Shibahara S. (2002). Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. EMBO J 21: 2703-2714.
118. Zhurinsky J, Shtutman M, Ben-Ze'ev A. (2000). Differential mechanisms of LEF/TCF family-dependent transcriptional activation by beta-catenin and plakoglobin. Mol Cell Biol 20: 4238-4252.